Aptar Digital Health Launches New Digital Disease Management Platform to Better Track Patient Treatment Adherence

Crystal Lake, Illinois, October 11, 2022 – Aptar Pharma, a global leader in drug delivery and active material science solutions and services, today announced the launch of a new Digital Disease Management Platform to support patients during their treatment journey. This new platform expands Aptar Pharma's portfolio of digital health solutions with a complete, end-to-end solution, supporting patients from the prevention and diagnosis phases, to disease management, and more, across multiple therapeutic areas.

By leveraging Aptar Digital Health’s Disease Management Platform, care teams can access real-time remote data monitoring to track the patient’s adherence to their treatment. Additionally, patients will get the support they need throughout every stage of their treatment journey, including remote patient diagnostic features, ePROS (Electronic Patient Reported Outcomes), virtual care and telehealth solutions, symptom and trigger tracking, as well as access to educational content and videos.

The Digital Disease Management Platform reflects Aptar Digital Health's commitment to deliver compliant, innovative and best-in-class solutions to optimize the management of chronic conditions for patients undergoing treatment at home. With this complete and easy-to-use platform, patients can benefit from active monitoring of disease evolution and easier communication with their care team, with the ultimate goal of helping patients improve their treatment adherence for better health outcomes.

“Aptar Pharma’s acquisitions of Cohero Health and Voluntis have allowed us to broaden our digital health expertise,” said Gael Touya, President of Aptar Pharma. “By offering all-in-one solutions including drug delivery connected devices, digital therapeutics and care services, we aim to reduce existing gaps in healthcare by empowering patients, improving treatment adherence and strengthening the patient and care team relationship.”

“With this new platform, we are accelerating the pace of change for digital healthcare solutions,” said Sai Shankar, President of Aptar Digital Health. ”Aptar Digital Health’s goal is to enhance patient experiences by providing continuous support and decentralized care. Our new offer consolidates our expertise in the field by proposing a solution that responds favourably to patient needs at each stage of their journey.”

Aptar Digital Health’s Digital Disease Management Platform is a new commercial offering to its life science industrial partners, payers and providers, and will be combined with long-term therapies for patients living with chronic conditions.

About Aptar Digital Health

Aptar Pharma's Digital Health division is part of AptarGroup, Inc., a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions and services. Aptar Digital Health creates end-to-end solutions to enhance patient experiences every day, leveraging a holistic ecosystem of digital interventions. Amplified by an industry-leading portfolio of products and solutions, Aptar Digital Health’s offerings combine mobile and web apps, connected drug delivery systems, onboarding, training and advanced data analytics services to actively empower patients and create a positive treatment journey. Aptar is headquartered in Crystal Lake, Illinois and has 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com.